脊髓损伤后延迟给予腹腔注射依那西普的疗效

摘要/Abstract

摘要： 目的：观察大鼠在脊髓损伤后延迟给予依那西普的后肢运动功能恢复和脊髓组织凋亡相关基因表达情况，并观察脊髓组织的病理改变。方法：72只成年雄性SPF级SD大鼠，随机分为6组（实验组为E1组、E2组、E3组，对照组为C1组、C2组、C3组），每组12只，采用70 g动脉瘤夹钳夹脊髓1 min制作钳夹型损伤模型，分别在损伤后即刻、1 h、8 h对实验组(E1组、E2组、E3组)予以腹腔注射依那西普1.25 mg/kg，对照组 (C1组、C2组、C3组)同样时间点予以腹腔注射生理盐水1 mL，每组取6只大鼠在损伤24 h后处死取脊髓组织，用Western blot法测定损伤处Bax 和Bcl-2表达情况，其余大鼠饲养14 d，期间每日予以Basso Beattie Bresnahan(BBB)运动功能评分，并在第14天处死取脊髓组织制成HE染色切片，光镜下观察。结果：(1) Bax和Bcl-2表达情况：E1组Bax表达灰度值为165.423±2.946，E2组为135.391±3.045，E3组为108.543± 6.999，对照组为69.054±0.774；E1组Bcl-2表达的灰度值为58.854±3.592，E2组为84.315±2.138，E3组为125.091±2.699，对照组为 156.304±2.490，以上各组数据差异均具有统计学意义(P<0.01)。(2)BBB评分结果：损伤后即刻或1 h给予依那西普可以明显改善大鼠BBB评分的恢复情况，进一步比较第14天BBB评分数据，E1组评分平均值为13.000±1.095，C1组为7.167±0.753，E2组为9.833±1.472，C2组为7.000± 0.632，以上各组数据差异均有统计学意义(P<0.05)，而E3组为7.333±0.516，C3组为6.833±0.753，两组差异无统计学意义(P>0.05)。(3)病理切片结果：光镜下观察E1组和E2组大鼠脊髓病理切片可见散在神经元细胞体，淋巴细胞、成纤维细胞浸润较少，组织坏死程度轻，而E3组和对照组可见大量淋巴细胞和成纤维细胞浸润，组织坏死严重。结论：脊髓损伤后注射依那西普可能会起到抑制脊髓组织凋亡的作用，但给药时间延迟超过8 h会显著降低其凋亡抑制作用，无法显著改善大鼠脊髓病理改变和促进后肢功能的恢复，依那西普用于脊髓损伤的实际临床价值仍有待进一步验证。

关键词: 依那西普, 脊髓损伤, 给药系统, 治疗结果

Abstract: Objective： To observe the effect of delayed administration of etanercept on the motor function, the expression of apoptosis-related genes and the pathological alterations of spinal cord in vivo in experimental murine model of spinal cord injury (SCI). Methods: Seventy-two male adult SD rats were randomly divided into 6 groups, which were subjected to SCI induced by the application of vascular clips (force of 70 g) to the dura. Experimental groups (E1, E2, and E3 group) were given administration of etanercept immediately, 1 h, and 8 h after SCI. The control groups (C1, C2, and C3 group) were given administration of saline at the same time as experimental groups. Six rats of each group were killed 24 h after SCI in order to collect the samples for testing the expression of Bax and Bcl-2 by Western blot. The rest were killed 14 d after SCI for observing the pathological alteration using light microscopy. The recovery of motor function was graded using the modified murine Basso, Beattle, and Bresnahan (BBB). Results: (1) The results of the expressions of Bax and Bcl-2 by Western blot: the gray value of the expression of Bax of E1 group was 165.423±2.946, of E2 group 135.391±3.045, of E3 group 108.543± 6.999, and of the control group 69.054±0.774, and the gray value of the expression of Bcl-2 of E1 group was 58.854±3.592, of E2 group 84.315±2.138, of E3 group 125.091±2.699, and of the control group 156.304±2.490. (2) The results of BBB score: etanercept given immediately or 1 h after SCI could improve the recovery of the rats. There were significant differences in BBB score 14 d after SCI between E1 group (13.000±1.095) and C1 group (7.167±0.753), E2 group (9.833±1.472) and C2 group (7.000±0.632) while there were no significant difference between E3 group (7.333±0.516) and C3 group (6.833±0.753). (3) The result of histological alteration: histological alterations, such as necrosis, infiltration of lymphocytes and fibroblast and loss of nerve cells, were found attenuated in E1 and E2 groups, compared with C1 and C2 groups. There was no obvious difference between E3 and C3 groups. Conclusion: Administration of etanercept may inhibit the apoptosis after SCI, but this kind of effect may be too weak to improve the BBB score and histological alterations obviously when administration of etanercept is delayed 8 h after SCI. The clinical value of etanercept to SCI needs to be further validated.

Key words: TNFR-Fc fusion protein, Spinal cord injuries, Medication systems, Treatment outcome

张恒维，刘海鹰，王波，朱震奇. 脊髓损伤后延迟给予腹腔注射依那西普的疗效[J]. 北京大学学报（医学版）, 2014, 46(1): 173-177.

ZHANG Heng-wei, LIU Hai-ying, WANG Bo, ZHU Zhen-qi. Efficacy of delayed administration of etanercept after spinal cord injury[J]. Journal of Peking University(Health Sciences), 2014, 46(1): 173-177.

参考文献

相关文章 15

[1]	李文菁,张保宙,李恒,赖良鹏,杜辉,孙宁,龚晓峰,李莹,王岩,武勇. 胫距跟融合治疗终末期踝和后足病变的中短期临床结果[J]. 北京大学学报（医学版）, 2024, 56(2): 299-306.
[2]	邹雪,白小娟,张丽卿. 艾拉莫德联合托法替布治疗难治性中重度类风湿关节炎的疗效[J]. 北京大学学报（医学版）, 2023, 55(6): 1013-1021.
[3]	薛蔚,董樑,钱宏阳,费笑晨. 前列腺癌新辅助治疗与辅助治疗的现状及进展[J]. 北京大学学报（医学版）, 2023, 55(5): 775-780.
[4]	邱敏,宗有龙,王滨帅,杨斌,徐楚潇,孙争辉,陆敏,赵磊,卢剑,刘承,田晓军,马潞林. 腹腔镜肾部分切除术治疗中高复杂程度肾肿瘤的效果[J]. 北京大学学报（医学版）, 2023, 55(5): 833-837.
[5]	王磊,韩天栋,江卫星,李钧,张道新,田野. 主动迁移技术与原位碎石技术在输尿管软镜治疗1~2 cm输尿管上段结石中的安全性和有效性比较[J]. 北京大学学报（医学版）, 2023, 55(3): 553-557.
[6]	李伟浩,李伟,张学民,李清乐,焦洋,张韬,蒋京军,张小明. 去分支杂交手术和传统手术治疗胸腹主动脉瘤的结果比较[J]. 北京大学学报（医学版）, 2022, 54(1): 177-181.
[7]	朱正达,高岩,何汶秀,方鑫,刘洋,魏攀,闫志敏,华红. 红色诺卡氏菌细胞壁骨架治疗糜烂型口腔扁平苔藓的疗效及安全性[J]. 北京大学学报（医学版）, 2021, 53(5): 964-969.
[8]	李潇,苏家增,张严妍,张丽琪,张亚琼,柳登高,俞光岩. ¹³¹I相关唾液腺炎的炎症分级及内镜治疗[J]. 北京大学学报（医学版）, 2020, 52(3): 586-590.
[9]	詹颖,杜祎甜,仰浈臻,张春丽,齐宪荣. 紫杉醇微球-原位凝胶的制备及其局部注射的抗肿瘤药效[J]. 北京大学学报（医学版）, 2019, 51(3): 477-486.
[10]	杨泽川,刘朝旭,林阳,胡伟华,陈文坚,李锋,曾恒. 颈后路单开门椎管扩大成形术全钛板与交替钛板、缝线固定治疗颈椎病的对比研究[J]. 北京大学学报（医学版）, 2019, 51(1): 187-193.
[11]	游文喆,窦桂丽,夏斌. 乳牙间接牙髓治疗两年疗效观察及影响因素分析[J]. 北京大学学报（医学版）, 2019, 51(1): 65-69.
[12]	李欣艺,赵金霞,刘湘源. 抗磷脂抗体相关性复发性流产的诊治:附75例抗磷脂综合征患者妊娠期用药和结局分析[J]. 北京大学学报（医学版）, 2018, 50(6): 956-961.
[13]	张茗茗，郑迎东，梁宇红. 牙髓根尖周病根管治疗疗效预测模型的建立[J]. 北京大学学报(医学版), 2018, 50(1): 123-130.
[14]	李旭, 李奉龙, 鲁谊, 朱以明, 郭斯翊, 李屹钧, 姜春岩. 锁定钢板治疗非骨质疏松性复杂肱骨近端骨折的中期临床及影像学随访研究[J]. 北京大学学报(医学版), 2017, 49(5): 855-860.
[15]	张维宇，张晓鹏，胡浩，陈京文，刘献辉，许克新. 无张力尿道中段悬吊术治疗女性混合性尿失禁的疗效分析[J]. 北京大学学报(医学版), 2017, 49(4): 638-642.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed